Sequence Bio, a biotechnology company researching the founder effect in Newfoundland and Labrador to accelerate novel drug target discovery, is pleased to announce that it has been selected to present four ePosters at ASHG 2020, the largest human genetics and genomics meeting and exposition in the world.
In their posters, members of Sequence Bio’s Research team will share insights from the company’s flagship genetic research study in Newfoundland and Labrador, the NL Genome Project. This includes an overview of Sequence Bio’s genetic characterization efforts, the technology and mechanisms developed to enable the return of research-grade genetic findings reports to study participants, and more:
Links to Sequence Bio’s ePosters will be available to conference attendees via ASHG’s virtual conference platform.
The ASHG Annual Meeting, produced by the American Society of Human Genetics (ASHG), is the largest human genetics and genomics meeting and exposition in the world. Held in October, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.
For more information, please visit ASHG.org
VP, Market Development